secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001079973-24-000876
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve issuance of up to 20.46M shares in Deerfield convertible notes and warrants
--------------------------------------------------------------------------------

- All nine director nominees elected with strong support; broker non-votes of ~12.2M shares.
- Ratification of BDO USA as independent auditor approved: 60.8M for, 192k against, 50k abstain.
- Proposal 3 approved: allows issuance of up to 20,459,040 shares upon conversion of Deerfield convertible notes and exercise of warrants.
- Turnout: 61.08M shares voted (82.06% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997324000876/0001079973-24-000876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997324000876/toi_8k-agm.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-000876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer